Serum levels of HMW adiponectin and its receptors are associated with cytokine levels and clinical characteristics in chronic obstructive pulmonary disease

Li Lu,Mengyu Cheng

DOI: https://doi.org/10.1515/med-2024-0904

2024-02-10

Open Medicine

Abstract:We aimed to investigate the changes in the levels of high-molecular-weight (HMW) adiponectin, adiponectin receptors, and cytokines in patients with chronic obstructive pulmonary disease (COPD), as well as their potential relationships. Forty-one patients who underwent lobectomy for lung lesions and had a clear postoperative pathological diagnosis were divided into the non-COPD ( N = 23) and COPD ( N = 18) groups. HMW adiponectin, cytokine, and T-cadherin levels in serum and tissues were detected by enzyme-linked immunosorbent assay. The levels of HMW adiponectin and cytokine (interleukin [IL]-6, IL-10, surfactant protein D, 4-hydroxynonenal, tumor necrosis factor-α, and C reactive protein) in the serum and tissues increased in the COPD group compared to those in the non-COPD group. Patients with COPD exhibited AdipoR1 upregulation and AdipoR2 downregulation. Although T-cadherin did not differ significantly between patients with and those without COPD, its expression was elevated during the progression from COPD with benign lung lesions to combined lung cancer. Furthermore, the HMW adiponectin levels were significantly correlated with the cytokine levels and the clinical characteristics of COPD. HMW adiponectin and its receptors affect the inflammatory process in COPD and may further contribute to the progression of the disease to malignancy.

medicine, general & internal

What problem does this paper attempt to address?

This paper aims to explore the changes in high - molecular - weight (HMW) adiponectin, adiponectin receptors and cytokine levels in the serum of patients with chronic obstructive pulmonary disease (COPD) and their potential relationships. Specifically, the researchers detected the levels of HMW adiponectin, cytokines (such as interleukin - 6 [IL - 6], IL - 10, surfactant protein D, 4 - hydroxynonenal, tumor necrosis factor - α and C - reactive protein) and T - cadherin in the serum and tissues of 41 patients who underwent lobectomy (23 of them were non - COPD patients and 18 were COPD patients) by enzyme - linked immunosorbent assay (ELISA). In addition, Western Blot technique was also used to evaluate the expression of adiponectin receptor 1 (AdipoR1), adiponectin receptor 2 (AdipoR2) and T - cadherin in tissues.

The study found that compared with the non - COPD group, the levels of HMW adiponectin and cytokines in the serum and tissues of COPD patients were significantly increased. The expression of AdipoR1 in COPD patients was up - regulated, while the expression of AdipoR2 was down - regulated. Although there was no significant difference in T - cadherin between COPD patients and non - COPD patients, its expression increased during the progression from benign lung lesions to combined lung cancer. In addition, the level of HMW adiponectin was significantly correlated with cytokine levels and clinical features of COPD, indicating that HMW adiponectin and its receptors may affect the inflammatory process of COPD and further promote the malignant progression of the disease.

Therefore, the problems that this paper attempts to solve are: in COPD patients, do the levels of HMW adiponectin, its receptors and cytokines change? Are these changes related to the inflammatory response and clinical features of COPD? Through the research of these problems, new perspectives can be provided for further understanding the pathological mechanism of COPD and may also provide new targets for the treatment of the disease.